Literature DB >> 14607613

Ovarian hyperstimulation syndrome.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14607613     DOI： 10.1016/s0015-0282(03)02194-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  10 in total

1.  Internal jugular vein thrombosis and ovarian hyperstimulation syndrome.

Authors:  D M Raw; M C Collins
Journal:  J R Soc Med       Date:  2007-07       Impact factor: 5.344

2.  GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.

Authors:  Kutluk Oktay; Ilgın Türkçüoğlu; Kenny A Rodriguez-Wallberg
Journal:  Reprod Biomed Online       Date:  2010-03-06       Impact factor: 3.828

Review 3.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome.

Authors:  Vittorio Fineschi; Margherita Neri; Sabina Di Donato; Cristoforo Pomara; Irene Riezzo; Emanuela Turillazzi
Journal:  Int J Legal Med       Date:  2006-06-02       Impact factor: 2.686

5.  In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-10-01

6.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

7.  Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement†‡.

Authors:  Richard S Legro; Xiaoke Wu; Kurt T Barnhart; Cynthia Farquhar; Bart C J M Fauser; Ben Mol
Journal:  Hum Reprod       Date:  2014-09-12       Impact factor: 6.918

8.  Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium.

Authors:  Jorge Rodriguez-Purata; Joseph Lee; Michael Whitehouse; Marlena Duke; Lawrence Grunfeld; Benjamin Sandler; Alan Copperman; Tanmoy Mukherjee
Journal:  J Assist Reprod Genet       Date:  2016-01-14       Impact factor: 3.412

9.  Follicle curetting at the time of oocyte retrieval increases the oocyte yield.

Authors:  Stephanie K Dahl; Sara Cannon; Mira Aubuchon; Daniel B Williams; Jared C Robins; Michael A Thomas
Journal:  J Assist Reprod Genet       Date:  2009-06-23       Impact factor: 3.412

10.  The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.

Authors:  Hannah A Nenonen; Ida A Lindgren; Alexandra S Prahl; Dorota Trzybulska; Isabella Kharraziha; Mathilda Hultén; Yvonne L Giwercman; Emir Henic
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.